Skip to main content
. 2013 Mar 21;5(6):1819–1825. doi: 10.3892/ol.2013.1268

Table II.

Comparison of clinicopathological findings between patients with main duct-type IPMN and branch duct-type IPMN.

Characteristic Main duct-type IPMN (n=33) Branch duct-type IPMN (n=67) P-value
Tumor marker, blood chemistry
  Carcinoembryonic antigen (ng/ml) 3.0±3.0 2.7±2.1 0.566
  Carbohydrate antigen 19–9 (U/ml) 55.5±88.0 48.1±182.7 0.850
Surgical period
  Immediately (%) 81.8 53.7 0.027
  Follow-up (%) 18.2 46.3
  Follow-up, median years (range) 1.6 (1–2) 3.6 (1–10) 0.021
Surgical procedure (n)
  Total pancreatectomy 4 2 0.143
  Pancreaticoduodenectomy 17 31
  Distal pancreatectomy 10 24
  Minimal invasive surgery 0 10
Pathology
  Adenoma 10 55
  Non-invasive carcinoma 14 3 0.001
  Invasive carcinoma 9 9

IPMN, intraductal papillary mucinous neoplasm.